Trials / Completed
CompletedNCT01181492
Impact of CYP3A4*1G Polymorphism on Metabolism of Fentanyl in Chinese Patients Undergoing Lower Abdominal Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 176 (actual)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: This study aimed to investigate the impact of CYP3A4\*1G genetic polymorphism on metabolism of fentanyl in Chinese patients undergoing lower abdominal surgery. Methods: 176 patients receiving elective lower abdominal surgery under general anesthesia were recruited into this study. Genotyping of CYP3A4\*1G was carried out by direct sequencing. The plasma fentanyl concentration was detected 30 min after anesthesia induction by high performance liquid chromatography-ultraviolet ray (HPLC-UV). The visual analog scale (VAS) was used for pain evaluation at rest during patient-controlled analgesia (PCA) treatment 0 h, 12 h and 24 h after operation. PCA fentanyl consumption and adverse effects were recorded during the first 24 h after surgery.
Conditions
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2010-08-13
- Last updated
- 2013-11-01
- Results posted
- 2013-11-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01181492. Inclusion in this directory is not an endorsement.